AISAP
Revolutionizes ultrasound with real-time guidance, instant interpretation, multi-organ diagnosis.. [Contact for Pricing]
Last verified:
What is AISAP?
AISAP is an AI-powered point-of-care ultrasound (POCUS) diagnostic platform that brings expert-level cardiac assessment to the bedside. Its flagship product, AISAP CARDIO, received FDA 510(k) clearance in August 2024 and serves as a comprehensive cloud-based platform combining AI diagnostics with detailed measurements for rapid, accurate diagnosis of structural heart disease and heart failure. The system integrates with any portable ultrasound device and enables clinicians with basic scanning skills to diagnose up to 90% of common cardiac structural and functional parameters within minutes at the point of care.
Key features include POCAD™ (Point of Care Assisted Diagnosis), AI-based diagnosis with four computer-assisted diagnosis modules for valvular pathologies, eight essential cardiac measurements, real-time scanning assistance for optimal image acquisition, a quick reviewing system, structured billable POCUS reports, performance dashboards, telemedicine capabilities, and seamless integration with EMR/EHR and PACS systems. The platform offers encrypted, secure architecture with HIPAA compliance and ISO 13485 certification, and has been clinically validated in trials at prestigious institutions including Mass General Brigham, Mayo Clinic, and Stony Brook University Hospital with 93% sensitivity and specificity for major valve diseases.
AISAP is designed for emergency medicine physicians, critical care doctors, internal medicine physicians, hospitalists, primary care physicians, cardiologists, and caregivers in academic hospitals, community/rural hospitals, urgent care centers, cardiology clinics, concierge practices, screening programs, and wellness clinics. It empowers non-cardiologists to interpret echocardiograms as accurately as expert cardiologists, making advanced cardiac diagnostics accessible in any healthcare setting from large academic centers to remote rural locations.
AISAP pricing
Pricing model: Freemium
The website does not publicly disclose specific pricing details, free tier options, or paid plan costs. AISAP operates as a user-friendly SAAS platform and requires users to request a demo for pricing information. Contact information provided is [email protected] for inquiries. The platform appears to be enterprise-focused for health systems, hospitals, and clinics rather than individual consumers.
AISAP pros
- FDA 510(k) cleared diagnostic algorithms for structural heart disease
- Diagnoses up to 90% of common cardiac parameters at bedside within minutes
- 93% sensitivity and 93% specificity for significant major valve diseases
- Works with any vendor's point-of-care ultrasound device (vendor-agnostic)
- Enables non-cardiologists to interpret echocardiograms as accurately as expert cardiologists
- Reduces reporting time by up to 90% with AI-powered smart reporting
- Increases billing to 95% by transforming images into billable encounters
- Seamless EMR/EHR and PACS integration fits existing clinical workflows
- Real-time scanning assistance ensures best image acquisition
- Cloud-based platform with secure HIPAA-compliant, ISO 13485 certified architecture
- Shortens hospital length of stay enabling timely discharge
- Avoids unnecessary patient transfers by providing bedside expert-level results
- Early detection of structural heart disease including aortic stenosis
- Trained on hundreds of thousands of studies with over 24 million echo video clips
- Validated in multi-national clinical trials at Mass General Brigham, Mayo Clinic, and more
- Built-in accreditation and QA tools standardize care quality
- Telemedicine and sharing capabilities for remote consultation
- Steep learning curve - can be taught within a few dozen hours
AISAP cons
- Requires internet connectivity for cloud-based platform functionality
- Limited to cardiac/structural heart disease assessment (CARDIO module)
- Requires purchase or ownership of separate POCUS ultrasound device
- SaaS subscription model may have ongoing costs not publicly disclosed
- May not replace formal echocardiography for all complex cases
- Training still required despite simplified learning curve
- AI algorithms may have bias if training data is non-uniform
- Limited generalizability potential as with most POCUS AI systems
Frequently asked questions about AISAP
What is AISAP CARDIO?
AISAP CARDIO is an FDA 510(k) cleared AI-powered point-of-care ultrasound (POCUS) software platform that combines four computer-assisted diagnosis modules for valvular pathologies and eight key cardiac measurements into a comprehensive package. It automatically generates analyses, interpretations, and reports, enabling clinicians with basic scanning skills to accurately diagnose up to 90% of common cardiac structural and functional parameters at the bedside within minutes.
What cardiac parameters does AISAP measure?
AISAP CARDIO assesses presence of valvular pathology including mitral regurgitation, tricuspid regurgitation, aortic regurgitation, and aortic stenosis. It also measures left ventricle ejection fraction (LVEF), right and left ventricular dimensions, right ventricular fractional area change (RV FAC), atrial areas, ascending aorta diameter, and inferior vena cava (IVC) diameter.
What ultrasound devices are compatible with AISAP?
AISAP is vendor-agnostic and integrates seamlessly with any point-of-care ultrasound (POCUS) device already in use. The platform works with multi-vendor ultrasound support, making it adaptable to various healthcare environments without requiring specific hardware.
How accurate is AISAP CARDIO?
AISAP CARDIO demonstrated 93% sensitivity and 93% specificity for significant major valve disease pathology (aortic stenosis and regurgitation, mitral and tricuspid regurgitation) in standalone performance studies. Data from clinical trials showed that non-cardiologist physicians using AISAP could interpret point-of-care echocardiograms just as well as expert cardiologists, with measurements often closer to the mean of three cardiologists than individual cardiologists.
Who should use AISAP?
AISAP is designed for emergency medicine physicians, critical care physicians, internal medicine physicians, hospitalists, primary care physicians, and cardiologists. It is used across academic and large hospitals, community and rural hospitals, urgent care centers, cardiology clinics, concierge and primary care practices, screening programs, and wellness and longevity clinics.
How long does it take to learn AISAP?
The AISAP system can be taught within a few dozen hours, which is significantly shorter than the training required for traditional ultrasound interpretation. Short training enables any caregiver to scan confidently, expanding capacity without requiring imaging specialists or laboratory assistance.
Is AISAP secure and compliant?
Yes, AISAP features encrypted and secure architecture with HIPAA compliance, ISO 13485 certification, data encryption, and other crucial protections to ensure security for institutions and patients. It provides a dedicated PACS that anonymizes DICOM files and stores them securely in the cloud or on-premise.
What is POCUS OS™?
POCUS OS™ is AISAP's seamless, all-in-one AI operating system platform for all point-of-care ultrasound needs. It integrates POCUS devices, cloud-based PACS, AI results, automated reporting, and EMR integration into a single workflow, boosting revenue to 95% billable encounters and reducing reporting time by up to 90%.
How does AISAP improve patient outcomes?
AISAP enables early detection of structural heart disease like aortic stenosis, shortens turnaround time with instant expert-level results at point of care, reduces hospital length of stay enabling timely discharge, avoids unnecessary patient transfers by providing bedside diagnostics, and accelerates diagnosis and treatment timelines, enhancing safety and patient satisfaction while optimizing revenue capture.
Where has AISAP been validated?
AISAP CARDIO has been validated in numerous retrospective and prospective trials on thousands of patients at renowned institutions including Mass General Brigham, Thomas Jefferson University Hospital, Mayo Clinic, Inova Fairfax Medical Campus, Crozer-Chester Medical Center, and Stony Brook University Hospital in multi-national, multi-site, randomized, multi-reader, multi-case clinical trials.